Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The science of global health diplomacy (GHD) consists of cross-disciplinary, multistakeholder credentials comprised of national security, public health, international affairs, management, law, economics and trade policy. GHD is well placed to bring about better and improved multilateral stakeholder leverage and outcomes in the prevention and control of cancer. It is important to create an evidence base that provides clear and specific guidance for health practitioners in low- and middle-income countries (LMICs) through involvement of all stakeholders. GHD can assist LMICs to negotiate across multilateral stakeholders to integrate prevention, treatment and palliative care of cancer into their commercial and trade policies.

Original publication




Journal article


Int Health

Publication Date





231 - 233


adverse effects of climate change, cancer policy and governance, global health diplomacy, health attachés, high-income countries, low- and middle-income countries, public–private partnerships, Commerce, Developing Countries, Diplomacy, Evidence-Based Medicine, Global Health, Government, Humans, Income, Interdisciplinary Communication, International Cooperation, Negotiating, Neoplasms, Policy, Poverty, Public Health, Stakeholder Participation